A Multi-center, Open Label, Dose Titration, Exploratory Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Esaxerenone (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 06 Apr 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 17 Dec 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 21 May 2015 New trial record